News from NORD

University of Pennsylvania Orphan Disease Center Posts RFPs


 

Grants made possible by the “Million Dollar Bike Ride” and rare disease patient organizations are now available through the University of Pennsylvania Orphan Disease Center. September 16 is the deadline for letters of intent.

The diseases for which research funding is available are: adult polyglucosan body disease; ataxia-telangiectasia; Castleman disease; CFTR nonsense mutations; congenital hyperinsulinism; congenital muscular dystrophy; CRB1 degenerative retinal disease; nonsense mutations in cystic fibrosis; dyskeratosis congenital & telomere biology disorders; fibrous dysplasia/McCune Albright syndrome; generalized lymphatic anomaly and Gorham-Stout disease; Glut 1 deficiency; lymphangioleiomyomatosis; mucolipidosis type IV; mucopolysaccharidoses; Niemann Pick type C; Pitt Hopkins syndrome; RASopathies; Tay-Sachs, Sandhoff, GM1, or Canavan disease; and Snyder-Robinson syndrome.

Recommended Reading

Myth of the Month: Vaccinations in patients with Guillain-Barré syndrome
MDedge Neurology
Can Coenzyme Q10 Supplementation Benefit Patients With MSA?
MDedge Neurology
NORD Announces 2016 Grant Opportunities
MDedge Neurology
Register Now for the NORD Summit!
MDedge Neurology
Running for Rare Team Raises Funds for NORD Program for Undiagnosed Patients
MDedge Neurology
Neuroendocrine Tumor Research Foundation Posts RFPs for $1.2 Million in Grants
MDedge Neurology
Research Training Fellowship in Ataxia is Available
MDedge Neurology
Guillain-Barré incidence rose with Zika across Americas
MDedge Neurology
Case-control study points to Zika virus as cause of microcephaly
MDedge Neurology
FDA approves Duchenne muscular dystrophy treatment under ‘accelerated pathway’
MDedge Neurology